VOR vs. CD
VOR (Vor Biopharma Inc.) and CD (Chaince Digital Holdings Inc) are both stocks. VOR operates in Biotechnology (Healthcare), while CD operates in Capital Markets (Financial Services). Over the past 5 years, VOR returned -49.22%/yr vs -7.87%/yr for CD. At a 0.07 correlation, their price movements are largely independent.
Performance
VOR vs. CD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VOR achieves a 9.79% return, which is significantly higher than CD's -4.43% return.
VOR
- 1D
- 1.92%
- 1M
- -1.85%
- YTD
- 9.79%
- 6M
- 14.79%
- 1Y
- 294.29%
- 3Y*
- -48.18%
- 5Y*
- -49.22%
- 10Y*
- —
CD
- 1D
- 0.00%
- 1M
- -42.70%
- YTD
- -4.43%
- 6M
- -33.94%
- 1Y
- 25.33%
- 3Y*
- 19.69%
- 5Y*
- -7.87%
- 10Y*
- -25.35%
VOR vs. CD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
VOR Vor Biopharma Inc. | 9.79% | -41.08% | -50.67% | -66.17% | -42.77% | -72.35% |
CD Chaince Digital Holdings Inc | -4.43% | -27.23% | 162.69% | 109.41% | -64.75% | -27.13% |
Correlation
The correlation between VOR and CD is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.06 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.05 |
Correlation (All Time) Calculated using the full available price history since Feb 5, 2021 | 0.07 |
Fundamentals
VOR:
-$53.66
CD:
-$0.23
VOR:
$0.00
CD:
$1.67M
VOR:
-$23.00K
CD:
-$1.10M
VOR:
-$1.13B
CD:
-$10.65M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VOR vs. CD — Risk / Return Rank
VOR
CD
VOR vs. CD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Vor Biopharma Inc. (VOR) and Chaince Digital Holdings Inc (CD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VOR | CD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.36 | ||
| Sortino ratioReturn per unit of downside risk | +1.48 | ||
| Omega ratioGain probability vs. loss probability | 1.38 | 1.21 | +0.17 |
| Calmar ratioReturn relative to maximum drawdown | 2.85 | 0.18 | +2.68 |
| Martin ratioReturn relative to average drawdown | 4.09 | 0.24 | +3.85 |
Loading charts...
Drawdowns
VOR vs. CD - Drawdown Comparison
The maximum VOR drawdown since its inception was -99.72%, roughly equal to the maximum CD drawdown of -99.79%. Use the drawdown chart below to compare losses from any high point for VOR and CD.
Loading charts...
Drawdown Indicators
| VOR | CD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.72% | -99.79% | +0.07% |
Max Drawdown (1Y)Largest decline over 1 year | -87.15% | -89.83% | +2.68% |
Max Drawdown (3Y)Largest decline over 3 years | -97.02% | -89.83% | -7.19% |
Max Drawdown (5Y)Largest decline over 5 years | -99.29% | -92.04% | -7.25% |
Max Drawdown (10Y)Largest decline over 10 years | — | -99.58% | — |
Current DrawdownCurrent decline from peak | -98.67% | -98.22% | -0.45% |
Average DrawdownAverage peak-to-trough decline | -88.69% | -90.00% | +1.31% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 60.71% | 67.26% | -6.55% |
Volatility
VOR vs. CD - Volatility Comparison
The current volatility for Vor Biopharma Inc. (VOR) is 23.24%, while Chaince Digital Holdings Inc (CD) has a volatility of 57.07%. This indicates that VOR experiences smaller price fluctuations and is considered to be less risky than CD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VOR | CD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.24% | 57.07% | -33.83% |
Volatility (6M)Calculated over the trailing 6-month period | 68.60% | 106.07% | -37.47% |
Volatility (1Y)Calculated over the trailing 1-year period | 171.72% | 187.20% | -15.48% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 116.35% | 151.80% | -35.45% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 116.73% | 146.04% | -29.31% |
Dividends
VOR vs. CD - Dividend Comparison
Neither VOR nor CD has paid dividends to shareholders.
Financials
VOR vs. CD - Financials Comparison
This section allows you to compare key financial metrics between Vor Biopharma Inc. and Chaince Digital Holdings Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
VOR and CD have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CD has higher volatility (57.07%) compared to VOR (23.24%). In terms of maximum drawdown, VOR dropped -99.72% vs CD's -99.79%.
VOR currently has the higher Sharpe Ratio (1.45 vs 0.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VOR and CD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer